Literature DB >> 3382630

Inhibition of sodium-calcium exchange in cardiac sarcolemmal membrane vesicles. 1. Mechanism of inhibition by amiloride analogues.

R S Slaughter1, M L Garcia, E J Cragoe, J P Reeves, G J Kaczorowski.   

Abstract

The mechanism by which terminal guanidino nitrogen substituted analogues of amiloride inhibit Na-Ca exchange in purified cardiac sarcolemmal membrane vesicles has been investigated. These inhibitors block both Nai-dependent Ca2+ uptake and Nao-dependent Ca2+ efflux. Inhibition of Na-Ca exchange monitored in K+ is noncompetitive vs Ca2+ but competitive vs Na+. Substitution of sucrose for K+ results in mixed kinetics of inhibition vs Ca2+, suggesting a complex interaction between inhibitor and carrier under this condition. Amiloride derivatives also block two other modes of carrier action: Na-Na exchange is inhibited in a competitive fashion with Na+ and kinetics of Ca-Ca exchange inhibition are mixed vs Ca2+ in either sucrose or K+. However, Ca-Ca exchange inhibition can be alleviated by increasing K+ concentration. Dixon analyses of Na-Ca exchange block with mixtures of inhibitors suggest that these agents are interacting at more than one site. In addition, Hill plots of inhibition are biphasic with Hill coefficients of 1 and 2 at low and high inhibitor concentrations, respectively. These results indicate that amiloride derivatives are mechanism-based inhibitors that interact at two classes of substrate-binding sites on the carrier; at low concentration they bind preferentially to a site that is exclusive for Na+, while at higher concentration they also interact at a site that is common for Na+, Ca2+, and K+.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3382630     DOI: 10.1021/bi00407a023

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  10 in total

1.  Calcium channels are present in the apical plasma membranes of the hepatopancreatic B-cells of Marsupenaeus japonicus.

Authors:  L Zilli; R Schiavone; L Ingrosso; S Marsigliante; V Zonno; C Storelli; S Vilella
Journal:  J Comp Physiol B       Date:  2003-09-09       Impact factor: 2.200

2.  Characterization of Na(+)-Ca2+ exchange activity in plasma membrane vesicles from postmortem human brain.

Authors:  G Hoel; M L Michaelis; W J Freed; J E Kleinman
Journal:  Neurochem Res       Date:  1990-09       Impact factor: 3.996

3.  A novel antagonist, No. 7943, of the Na+/Ca2+ exchange current in guinea-pig cardiac ventricular cells.

Authors:  T Watano; J Kimura; T Morita; H Nakanishi
Journal:  Br J Pharmacol       Date:  1996-10       Impact factor: 8.739

4.  Characteristics of Na(+)-Ca2+ exchange in frog skeletal muscle.

Authors:  A Hoya; R A Venosa
Journal:  J Physiol       Date:  1995-08-01       Impact factor: 5.182

5.  The novel Na(+)/Ca(2+) exchange inhibitor KB-R7943 also blocks native and expressed neuronal nicotinic receptors.

Authors:  A J Pintado; C J Herrero; A G García; C Montiel
Journal:  Br J Pharmacol       Date:  2000-08       Impact factor: 8.739

6.  Calcium absorption by fish intestine: the involvement of ATP- and sodium-dependent calcium extrusion mechanisms.

Authors:  G Flik; T J Schoenmakers; J A Groot; C H van Os; S E Wendelaar Bonga
Journal:  J Membr Biol       Date:  1990-01       Impact factor: 1.843

7.  The effects of quinidine on sodium-dependent calcium efflux in isolated rod photoreceptors of the salamander retina.

Authors:  L Lagnado; P A McNaughton
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

Review 8.  Clinical potential of sodium-calcium exchanger inhibitors as antiarrhythmic agents.

Authors:  Steven M Pogwizd
Journal:  Drugs       Date:  2003       Impact factor: 9.546

9.  Voltage dependence of Na-Ca exchanger conformational currents.

Authors:  E Niggli; P Lipp
Journal:  Biophys J       Date:  1994-10       Impact factor: 4.033

10.  Amiloride inhibits the vasopressin-induced increase in epithelial water permeability.

Authors:  A Grosso; E J Cragoe; R C DeSousa
Journal:  Pflugers Arch       Date:  1990-10       Impact factor: 3.657

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.